Investigation of Biopsychosocial Characteristics of Individuals with Knee Osteoarthritis
1 other identifier
observational
100
1 country
1
Brief Summary
Since pain and depression are observed together in rheumatic diseases, the concept of limitation caused by the disease and health-related quality of life becomes more determinant than radiological joint damage. Sleep problems observed in OA also increase the level of depression findings and difficulty in movement. The chronic nature of the disease includes issues such as pain, fatigue, sleep problems, loss of function, anxiety, depression, and social isolation, together as in other chronic diseases. This complex structure accompanies a picture in which inflammatory processes are triggered. When the literature is examined, the necessity of evaluation and methods including all these biopsychosocial characteristics of chronic diseases with multifaceted symptoms is emphasized. On the other hand, although it is stated that the common goal of non-pharmacological treatments is to contribute to biopsychosocial improvement in the patient, it is emphasized that evaluations with biopsychosocial content are insufficient. This situation causes the need for scales that provide a holistic assessment of chronic diseases. When the literature, including individuals diagnosed with osteoarthritis, is analyzed, the inadequacy of the studies providing biopsychosocial evaluation draws attention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 9, 2027
February 12, 2025
August 1, 2024
2.5 years
September 8, 2024
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive Exercise Therapy Approach (BETY)- Biopsychosocial Questionnaire
The BETY Questionnaire was developed on rheumatic patients and was introduced to the literature as a standardized biopsychosocial measurement tool as a result of improving the definitions of recovery from patients with expert opinions and statistical analysis. Scoring of the scale is done using a 5-point Likert system, each item is scored between 0 and 4 points, and a high total score in the scale consisting of a total of 30 items indicates a high biopsychosocial impact.
3 mounths
Secondary Outcomes (14)
Health Asessement Questionnaire (HAQ)
3 mounths
Hospital Anxiety Depression Scale (HADS)
3 mounths
Short Form - 36
3 mounths
WOMAC Osteoarthritis Index
3 mounths
Pain Catastrophizing Scale
3 mounths
- +9 more secondary outcomes
Interventions
The home exercise program routinely given to individuals with knee OA in addition to their medical treatment will consist of exercises routinely used in the BETY innovation.
Eligibility Criteria
The study population will consist of individuals who come to the university hospital for routine controls.
You may qualify if:
- Diagnosis of knee osteoarthritis according to ACR knee osteoarthritis diagnostic criteria
- Being in stage 2 or 3 according to Kellgren-Lawrence radiological staging criteria
- To be 18 years of age or older
- Being a reader-writer
- Having read and signed the informed consent
You may not qualify if:
- History of major psychiatric illness
- Having malignant disease
- Having chronic infectious or other rheumatologic diseases
- Serious knee trauma or surgical operation in the last 6 months
- Having collagen tissue disease
- History of peripheral vascular disease or neuropathy
- Being in stage 4 according to Kellgren Lawrence radiologic staging criteria
- To have received a physiotherapy program for the relevant knee in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aysima Barlaklead
Study Sites (1)
Hacettepe University
Ankara, Altındağ, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PT
Study Record Dates
First Submitted
September 8, 2024
First Posted
September 19, 2024
Study Start
March 1, 2025
Primary Completion (Estimated)
September 9, 2027
Study Completion (Estimated)
September 9, 2027
Last Updated
February 12, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share